Table 2 Clinical outcomes after at least 1-year standardized treatments for VTDR
Total | ≤ 45 years | > 45 years | P | |
|---|---|---|---|---|
TRD involving foveal (n = 736) | 146 (19.8%) | 50 (34.7%) | 96 (16.2%) | < 0.001* |
Final BCVA < 0.3 (n = 736) | 413 (56.1%) | 85 (59.0%) | 328 (55.4%) | 0.432 |
Recurrent VH (n = 359) | 44 (12.3%) | 16 (18.6%) | 28 (10.3%) | 0.040* |
NVG (n = 736) | 60 (8.2%) | 11 (7.6%) | 49 (8.3%) | 0.802 |